Cargando…

Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease

Due to the heterogeneity of amyloid β-42 (Aβ(42)) species, the potential correlation between plasma oligomeric Aβ(42) (oAβ(42)) and cognitive impairments in cerebral small vessel disease (CSVD) remains unclear. Herein, a sandwich ELISA for the specific detection of Aβ(42) oligomers (oAβ(42)) and tot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Wensheng, Zhang, Liding, Liang, Xiaohan, Yu, Zhiyuan, Huang, Hao, Zhao, Jing, Guo, Yinping, Zhou, Xirui, Xu, Shabei, Luo, Haiming, Luo, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855662/ https://www.ncbi.nlm.nih.gov/pubmed/36671945 http://dx.doi.org/10.3390/bios13010110

Ejemplares similares

Sleep Quality Mediates the Association Between Cerebral Small Vessel Disease Burden and Frailty: A Community-Based Study
por: Zhao, Jing, et al.
Publicado: (2021)

Dynamic Changes in the Levels of Amyloid-β(42) Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease
por: Zhang, Liding, et al.
Publicado: (2021)

Differences in Gray Matter Volume in Cerebral Small Vessel Disease Patients with and without Sleep Disturbance
por: Zhao, Jing, et al.
Publicado: (2023)

Association of Excessive Daytime Sleepiness with Cerebral Small Vessel Disease in Community-Dwelling Older Adults
por: Zhao, Jing, et al.
Publicado: (2022)

Type A personality, sleep quality, and cerebral small vessel disease: investigating the mediating role of sleep in a community-based study
por: Zhou, Xirui, et al.
Publicado: (2023)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017)

Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer’s disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay
por: Zhang, Liding, et al.
Publicado: (2023)

Serum Cortisol Is Associated With Cerebral Small Vessel Disease-Related Brain Changes and Cognitive Impairment
por: Qiu, Qianwen, et al.
Publicado: (2022)

Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
por: Gericke, Christoph, et al.
Publicado: (2020)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Heart rate variability is associated with cerebral small vessel disease in patients with diabetes
por: Qiu, Qianwen, et al.
Publicado: (2022)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Effect of Cerebral Small Vessel Disease Burden on Outcomes in Patients With Acute Ischemic Stroke Receiving Endovascular Treatment
por: Huang, Hao, et al.
Publicado: (2022)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation
por: Vadukul, Devkee M., et al.
Publicado: (2023)

Elevated RANTES levels are associated with increased risk of cerebral atherosclerotic stenosis
por: Guo, Yinping, et al.
Publicado: (2023)

Asymmetry of Lacunae between Brain Hemispheres Is Associated with Atherosclerotic Occlusions of Middle Cerebral Artery
por: Wu, Lingshan, et al.
Publicado: (2023)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
por: Babapour Mofrad, Rosha, et al.
Publicado: (2021)

Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study
por: Wu, Lingshan, et al.
Publicado: (2023)

Envisaging the Structural Elevation in the Early Event of Oligomerization of Disordered Amyloid β Peptide
por: Roy, Anupam, et al.
Publicado: (2017)

Combination of plasma amyloid beta((1-42/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
por: Verberk, Inge M. W., et al.
Publicado: (2020)

Vascular Risk Predicts Plasma Amyloid β 42/40 Through Cerebral Amyloid Burden in Apolipoprotein E ε4 Carriers
por: Sapkota, Shraddha, et al.
Publicado: (2023)

Addition of Aβ(42) to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
por: Liu, Jianping, et al.
Publicado: (2021)

Effects of α-Lipoic Acid on Phagocytosis of Oligomeric Beta-Amyloid(1–42) in BV-2 Mouse Microglial Cells
por: Ko, Chih-Yuan, et al.
Publicado: (2022)

Decoding the Roles of Amyloid-β (1–42)’s Key Oligomerization Domains toward Designing Epitope-Specific Aggregation Inhibitors
por: Im, Dongjoon, et al.
Publicado: (2023)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

Oligomeric Amyloid-β Peptide on Sialylic Lewisx–Selectin Bonding at Cerebral Endothelial Surface
por: Askarova, Sholpan, et al.
Publicado: (2014)

Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay
por: Zhang, Liding, et al.
Publicado: (2021)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
por: Yu, Chunjiang, et al.
Publicado: (2010)

Amyloid Depositions and Small Vessel Disease in Patients with Cerebral Amyloid Angiopathy: a Case Series
por: Hong, Yun Jeong, et al.
Publicado: (2020)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
por: Kaiser, Elmar, et al.
Publicado: (2011)

Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism
por: Liu, Ni, et al.
Publicado: (2022)

Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation
por: Wolff, Martin, et al.
Publicado: (2015)

Increased plasma amyloid-β(42) protein in sporadic inclusion body myositis
por: Abdo, Wilson F., et al.
Publicado: (2009)

The Role of Age on Beta-Amyloid(1–42) Plasma Levels in Healthy Subjects
por: Zecca, Chiara, et al.
Publicado: (2021)

A common pathway for detergent-assisted oligomerization of Aβ42
por: Muhammedkutty, Fidha Nazreen Kunnath, et al.
Publicado: (2023)

Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation
por: Akhtar, Mohd Waseem, et al.
Publicado: (2016)

Geniposide Protects Primary Cortical Neurons against Oligomeric Aβ(1-42)-Induced Neurotoxicity through a Mitochondrial Pathway
por: Zhao, Chunhui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_75pecaskj6vasetamjdkr51op4